American Well stock jumped almost 25% to US$13.02 today, a sharp move for a telehealth platform that is still reporting losses and modest revenue. The market is cheering one thing above all else. Q2 brought the closest the company has been to breakeven adjusted earnings before interest, taxes, depreciation and amortization, with an adjusted EBITDA loss of about US$1.2m on US$52m of revenue.
That shift in the profit trajectory, supported by a cash pile of roughly US$196m and no debt, is what now matters more than any single quarter’s revenue line. The rest of the earnings story flows from that margin grind toward sustainability.
Is American Well’s sharp move just sentiment chasing breakeven, or does the current price already assume a full turnaround in margins and growth? See how the stock screens on our valuation analysis for American Well
Prefer clean, visual charts over another wall of earnings tables and footnotes? See American Well’s full financial picture, including its valuation, at a glance in our company report for American Well.
Bulls argue American Well is turning into a higher margin infrastructure and subscription business, supported by federal wins and cost cuts. The Q2 numbers show real progress on that playbook. Subscription revenue is now more than half of total revenue and grew slightly sequentially, even as total revenue declined. AMG visit revenue is higher and paid visits are roughly flat, while revenue per visit is higher, which supports the claim of a shift toward higher value programs.
The more important milestone is profitability. Operating expenses fell sharply and adjusted EBITDA loss narrowed to about US$1.2m. That is consistent with management’s goal of breakeven adjusted EBITDA and positive operating cash flow in Q4 2026. The DHA intent to award is not yet a contracted revenue stream, but it supports the idea that American Well’s platform is being treated as core infrastructure by large customers.
Reveal where the surface looks calm but the models start to disagree on American Well’s next few years, and see where the consensus might quietly be drawing the next inflection point by accessing the analyst estimates for American Well.Bears argue American Well is stuck with fragile revenue that leans too heavily on shrinking government and software contracts, with visit growth and pricing unable to fill the hole. Q2 leans toward their side on the top line. Total revenue fell 26.6% year on year and subscription revenue fell 36.5%, even though it now makes up more than half of sales. Management cites portfolio pruning, but the burden of proof now sits with future quarters to show this is a reset rather than structural pressure.
The bear narrative on profitability and cash burn is only partly challenged. Adjusted EBITDA is close to breakeven and operating expenses fell sharply, so near term dilution risk looks lower. However, guidance still calls for a full year adjusted EBITDA loss and Q3 margins are expected to step back. Until subscription revenue stabilizes more clearly, the core revenue durability worry remains intact.
After a 24.9% one-day jump and ongoing losses, it is worth asking whether this is just the visible risk. Review our structured risk analysis for American Well which shows 3 important warning signsIf American Well’s sharp move toward breakeven has your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch how the margin story evolves. Once you have taken a position, use the Portfolio Command Center to cut through market noise and focus on the updates that matter for your holdings. For longer term context, the Community helps you see how other investors are thinking about the same risks and catalysts. By surfacing potential turning points and pressure points early, Simply Wall St helps you stay ahead of the market and make decisions with more confidence.
Fresh stock ideas can move quickly, and early interest often sets the tone for the next potential breakout. Scan focused lists that may still be under the radar for now to evaluate opportunities at an earlier stage.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com